MRM (MEDIROM Healthcare Technologies) Altman Z2-Score: -0.88 (As of Jun. 29, 2026)


MRM MEDIROM Healthcare Technologies Inc MRM
53 GF Score
Price $0.96
GF Value $4.08
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is MEDIROM Healthcare Technologies Altman Z2-Score?

MEDIROM Healthcare Technologies MRM -1.26% 53 Altman Z2-Score is -0.88 as of Jun. 29, 2026. GuruFocus rates MRM with a GF Score™ of 53/100 and a GF Value™ of $4.08 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 97 Personal Services companies, MEDIROM Healthcare Technologies ranks worse than 81.44% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

MEDIROM Healthcare Technologies has a Altman Z2-Score of -0.88, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for MEDIROM Healthcare Technologies's Altman Z2-Score or its related term are showing as below:

MRM' s Altman Z2-Score Range Over the Past 10 Years
Min: -4.1   Med: -2.24   Max: -0.88
Current: -0.88

During the past 7 years, MEDIROM Healthcare Technologies's highest Altman Z2-Score was -0.88. The lowest was -4.10. And the median was -2.24.


MEDIROM Healthcare Technologies  (NAS:MRM) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


MEDIROM Healthcare Technologies Altman Z2-Score Related Terms


MEDIROM Healthcare Technologies Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for MEDIROM Healthcare Technologies's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDIROM Healthcare Technologies Altman Z2-Score Chart

MEDIROM Healthcare Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Altman Z2-Score
Get a 7-Day Free Trial -2.24 -4.10 -2.29 -1.60 -0.88

MEDIROM Healthcare Technologies Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -1.60 0.00 -0.88 0.00

MRM vs EJH, CLIK, DROR: Altman Z2-Score Comparison

For the Personal Services subindustry, MEDIROM Healthcare Technologies's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MEDIROM Healthcare Technologies Altman Z2-Score vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, MEDIROM Healthcare Technologies's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where MEDIROM Healthcare Technologies's Altman Z2-Score falls into.


MRM
53GF Score
MEDIROM Healthcare Technologies Inc MRM
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MEDIROM Healthcare Technologies Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

MEDIROM Healthcare Technologies's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*-0.1824+3.26*0.0283+6.72*0.012+1.05*0.1352
=-0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2024:
Total Assets was $52.60 Mil.
Total Current Assets was $17.59 Mil.
Total Current Liabilities was $27.19 Mil.
Retained Earnings was $1.49 Mil.
Pre-Tax Income was $0.31 Mil.
Interest Expense was $-0.32 Mil.
Total Liabilities was $44.88 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(17.593 - 27.185)/52.6
=-0.1824

X2=Retained Earnings/Total Assets
=1.489/52.6
=0.0283

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(0.31 - -0.323)/52.6
=0.012

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(6.067 - 0)/44.876
=0.1352

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

MEDIROM Healthcare Technologies has a Altman Z2-Score of -0.88 indicating it is in Distress Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of -0.88 mean?
MEDIROM Healthcare Technologies (MRM) has a Altman Z2-Score of -0.88 as of Jun. 29, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on MEDIROM Healthcare Technologies and its competitors. According to the industry distribution chart, MEDIROM Healthcare Technologies ranks #79 out of 97 companies in the Personal Services industry, placing it in the top 81.4%.
Is MEDIROM Healthcare Technologies' Altman Z2-Score too high?
MEDIROM Healthcare Technologies' current Altman Z2-Score is -0.88. Based on the distribution chart, MEDIROM Healthcare Technologies ranks #79 out of 97 companies in the Personal Services industry, which is in the bottom quartile relative to peers. Overall, MEDIROM Healthcare Technologies has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MEDIROM Healthcare Technologies' Altman Z2-Score compare to EJH and CLIK?
According to the Personal Services industry distribution chart, MEDIROM Healthcare Technologies ranks #79 out of 97 companies for Altman Z2-Score. This places MEDIROM Healthcare Technologies in the lower half of its industry. The industry median Altman Z2-Score is 1.98. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Personal Services company?
The median Altman Z2-Score among Personal Services companies is 1.98, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on MEDIROM Healthcare Technologies and its competitors. For the Personal Services industry, the median Altman Z2-Score is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDIROM Healthcare Technologies's current Altman Z2-Score is -0.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDIROM Healthcare Technologies stock overvalued right now?
Based on GuruFocus' analysis, MEDIROM Healthcare Technologies (MRM) is currently considered Possible Value Trap. The stock's GF Value™ is $4.08, compared to a current price of $0.96 — trading 76.5% below its estimated fair value. The current Altman Z2-Score is -0.88. MEDIROM Healthcare Technologies' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For MEDIROM Healthcare Technologies (MRM), the current Altman Z2-Score is -0.88 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MEDIROM Healthcare Technologies (MRM) Overvalued in 2026?

Based on GuruFocus' analysis, MEDIROM Healthcare Technologies stock appears to be undervalued. The current stock price of $0.96 is trading 76.5% below its estimated GF Value™ of $4.08. GuruFocus considers MEDIROM Healthcare Technologies to be Possible Value Trap.

Key valuation signals for MRM:

  • Altman Z2-Score: -0.88
  • GF Value™: $4.08 vs. price of $0.96 (76.5% below fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the MRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MEDIROM Healthcare Technologies Business Description

Address 2-3-1 Daiba, 16th Floor, Tradepia Odaiba, Minato-ku, Tokyo, JPN, 135-0091
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
53GF Score

Get the complete analysis for MRM

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.96
Price
$4.08
GF Value